Funding Details
- Awarder
- Inbox
- Date Award
- June 12, 2024
- Vertical
- AI health tech
- Funding URL
- View Funding Page
- Valuation
-
$8,100,000
Company Info
- Founding Year
- 2015
- Traction
- Tempus has shown strong revenue growth, reaching $531 million in 2023. The company is focused on genomic testing and data analysis in the healthcare sector.
- Revenue Amount
-
$531,000,000
- Organizations Involved
- NEA, Revolution Growth, T. Rowe Price, Novo Holdings, Franklin Templeton, Baillie Gifford, SoftBank
- Founders
- Eric Lefkofsky
- Company Description
- Tempus is a genomic testing and data analysis company founded by Eric Lefkofsky in 2015. The company focuses on applying technology to cancer care to help physicians make data-driven decisions. Tempus has shown significant revenue growth, reaching $531 million in 2023, with a focus on genomic testing and data analysis in the healthcare sector.
- Market
- Healthcare
- Location
-
Chicago,
IL,
US
- Coinvestors
- NEA, Revolution Growth, T. Rowe Price, Novo Holdings, Franklin Templeton, Baillie Gifford, SoftBank
Links